These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 28084973)
1. Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes. Pick JM; Batra AS Cardiol Young; 2017 Jan; 27(S1):S126-S131. PubMed ID: 28084973 [TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426 [TBL] [Abstract][Full Text] [Related]
13. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262 [TBL] [Abstract][Full Text] [Related]
14. [Primary prevention of sudden cardiac death through a wearable cardioverter-defibrillator]. Gabrielli D; Benvenuto M; Baroni M; Oliva F; Capucci A G Ital Cardiol (Rome); 2015; 16(7-8):418-25. PubMed ID: 26228611 [TBL] [Abstract][Full Text] [Related]
15. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ Cardiol Rev; 2002; 10(3):173-81. PubMed ID: 12047795 [TBL] [Abstract][Full Text] [Related]
16. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy. Maron BJ; Maron MS Heart Rhythm; 2016 May; 13(5):1155-1165. PubMed ID: 26749314 [TBL] [Abstract][Full Text] [Related]
17. Sudden death and hypertrophic cardiomyopathy: a review. Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263 [TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up. Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378 [TBL] [Abstract][Full Text] [Related]
19. Risk stratification for sudden death in arrhythmogenic right ventricular cardiomyopathy. Cadrin-Tourigny J; Tadros R; Talajic M; Rivard L; Abadir S; Khairy P Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):653-64. PubMed ID: 25947965 [TBL] [Abstract][Full Text] [Related]
20. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death]. Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]